For more context, try this NYTimes article: https://www.nytimes.com/2023/07/22/business/gilead-hiv-drug-tenofovir.html https://www.nytimes.com/2023/07/22/busine

For more context, try this NYTimes article: https://www.nytimes.com/2023/07/22/business/gilead-hiv-drug-tenofovir.html https://www.nytimes.com/2023/07/22/business/gilead-hiv-drug-... > In private, though, something else was at play. Gilead had devised a plan to delay the new drug’s release to maximize profits, even though executives had reason to believe it might turn out to be safer for patients, according to a trove of internal documents made public in litigation against the company.